Public Lecture- Professor Jan-Inge Henter
What's this fundraiser about?
Our Research team has collaborations around the globe in our quest to find more effective ways to diagnose and treat cancer. One of these collaborations is with Professor Jan-Inge Henter from the Karolinska Institutet, Stockholm, who will shortly visit the Institute the inaugural Visiting John Turner Professorship. The visit will focus on our collaborative ground-breaking work on Langerhans cell histiocytosis (LCH). LCH is a rare cancer that damages tissue or causes lesions to form in one or more places on the body, occurring at any age, but is most commonly in young children. Professor Jan-Inge Henter is a prize winning and internationally recognised researcher in the field of Hematology and Oncology. Since completing his PhD in 1990, his research has focused on hemophagocytic lymphohistiocytosis (HLH), a life-threatening and rare immunodeficiency, in which the body makes too many activated immune cells. Professor Henter was awarded a Professorship at the Karolinska Institute in 2004. The Karolinska Institute is one of the world’s foremost medical universities and centres of medical academic research. In addition, Professor Henter is also part of the esteemed Nobel Assembly at the Karolinska Institute, that has since 1901 selected the Nobel Prize laureates in Physiology or Medicine. Professor Henter will host a public lecture, Monday 9 October 7pm at the Institute-"Life-threatening hyperinflammation: Association with cancer, severe infections and inflammatory disorders”Presentation will be relevant to many areas of medicine and science including cancer, intensive care, many inflammatory diseases and paediatrics. To RSVP email email@example.com or calling (03) 5331 3101